Financhill is a comprehensive financial analysis platform that provides stock analysis, market data, investment tools, and educational resources to help investors make informed decisions.

How do I get started with Financhill?

You can start by creating a free account, exploring our stock analysis tools, setting up a watchlist, or trying our 7-day trial for full access to all premium features.

What features does Financhill offer?

Financhill offers stock analysis, technical charts, fundamental data, earnings information, dividend tracking, portfolio management, market screening tools, and educational resources.

What are 10K annual reports?

10K reports are comprehensive annual reports filed by public companies with the SEC, containing detailed financial statements, business operations, risk factors, and management discussion.

How often are annual reports updated?

Annual reports are typically filed once per year, usually within 60-90 days after the company's fiscal year end. We update our database as soon as new reports become available.

How do I analyze REPL stock?

Use our comprehensive analysis tools including technical charts, fundamental metrics, earnings data, and Stock Score to evaluate REPL investment potential.

What is REPL stock price today?

Get real-time REPL stock price, historical data, and price charts on Financhill. Track REPL performance with our advanced analysis tools.

Is REPL a good investment?

Evaluate REPL investment potential using our Stock Score, fundamental analysis, technical indicators, and earnings data. Consider your risk tolerance and investment goals.

How to buy REPL stock?

To buy REPL stock, open a brokerage account, research the company using our analysis tools, and place your order through your broker. Always do your own research before investing.

What is the market cap of REPL?

View detailed market capitalization data and company valuation metrics for REPL on our comprehensive analysis page.

What is the P/E ratio of REPL?

Use our fundamental analysis tools to view REPL P/E ratio and compare valuation metrics with industry peers.

What are REPL earnings?

View REPL earnings data, quarterly results, revenue growth, and profit margins on our comprehensive earnings analysis page. Track earnings trends and analyst estimates.

Back

Replimune Group, Inc. 10K Form

Buy

REPL
Replimune Group, Inc.

Last Price:

$10.52

Seasonality Move:

-2.1%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive REPL News And Ratings

See the #1 stock for the next 7 days that we like better than REPL

REPL Financial Statistics

Sales & Book Value

Annual Sales:	$0
Cash Flow:	$-82.6M
Price / Cash Flow:	0
Annual Sales:	$3.36
Price / Book:	3.14

Profitability

EPS (TTM):	-3.60760
Net Income (TTM):	$-310.3M
Gross Margin:	$-3.5M
Return on Equity:	-82.53%
Return on Assets:	-61.75%

Replimune Group, Inc. Earnings Forecast

Key Replimune Group, Inc. Financial Ratios

Per Share Earnings over the last 9 years have been positive in 1 years.

Replimune Group, Inc. Stock Price Chart

Industry, Sector and Symbol

Stock Exchange:	NASDAQ
Industry:	Biotechnology
Sector:	Health Care
Current Symbol:	REPL
CUSIP:	76029N
Website:	replimune.com

Debt

Debt-to-Equity Ratio:	0.29
Current Ratio:	6.31
Quick Ratio:	6.12

Price-to-Earnings

Trailing P/E Ratio:	0
Forward P/E Ratio:	0

REPL Technical Analysis vs Fundamental Analysis

Buy

Replimune Group, Inc. (REPL) is a Buy

Is Replimune Group, Inc. a Buy or a Sell?

Replimune Group, Inc. stock is rated a Buy

The current Replimune Group, Inc. [REPL] share price is $10.53. The Score for REPL is 71, which is 42% above its historic median score of 50, and infers lower risk than normal.